Infectious Diseases

Given the high prevalence of Kawasaki disease during the pandemic, Japanese investigators determined that droplet or contact transmission of pathogens is likely not a major route causing the development of the disease.

Michael Osterholm, PhD, MPH, warns that the B.1.1.7 variant of coronavirus disease 2019 could necessitate a return to at-home school because of the variant’s impact on children.

Pfizer/BioNTech has released data on their coronavirus disease 2019 (COVID-19) vaccine that indicates that its highly effective in children aged 12 to 15 years.

Summer camp is a source of fun, socialization, and memories for many children. The American Academy of Pediatrics (AAP) has offered information for families, clinicians, and camp staff to ensure safe attendance as the pandemic continues.

Social and family factors can have a large impact on a child’s health outcomes. A report examines how they can impact respiratory syncytial virus hospitalization.

The coronavirus disease 2019 (COVID-19) pandemic has impacted health care delivery in a variety of areas. A report investigates what’s happened with pediatric cancer delivery.

New research has led to the Centers for Disease Control and Prevention revising recommendations for distancing in schools from 6 to 3 feet in most situations.

As the world has changed because of coronavirus disease 2019, the digital world has kept pace with ever-changing best practices and guideline updates.

Some cases of multisystem inflammatory syndrome in children (MIS-C) can have severe outcomes. An investigation examined if certain demographic and clinical characteristics are linked to those outcomes.

Moderna announces beginning of coronavirus disease 2019 (COVID-19) vaccine trial that include children aged 6 months to >12 years.

Dr. Tan looks toward what the coronavirus disease 2019 vaccine rollout could look like in pediatrics and shares her must-read articles from the March 2021 issue of Contemporary Pediatrics.

The push to responsibly use antibiotics has led to shorter treatment courses when the efficacy is similar to a longer one. A study examines whether shorter courses could be effective in treating community-acquired pneumonia.

In this morning’s briefing, the Infectious Diseases Society of America (IDSA) addressed the safety of returning to school and what the future may hold for pediatric vaccination for coronavirus disease 2019.

Coronavirus disease 2019 (COVID-19) is more than a disease that attacks the respiratory system. An investigation examines the neurologic involvement during COVID-19.

Coronavirus 2019 disease (COVID-19) is often mild, but can lead to cardiovascular harm. Ensuring the safe return to sports by affected children will be a necessity.

The Centers for Disease Control and Prevention (CDC) has issued interim guidance for masking, social distancing, hand hygiene, and other infection control measures for people who are fully vaccinated for coronavirus 2019 disease (COVID-19).

A 17-year-old male patient presents with multiple lesions developed on his trunk, face, and extremities that had previously been solitary, red expanding lesion on his right arm at the site of a tick bite that occurred during a hike.

Many mask mandates don’t require young children to wear masks. A new investigation indicates that young children can wear masks without any respiratory distress.

In a briefing this morning, the Infectious Diseases Society of America (IDSA) stressed the continued importance of coronavirus 2019 disease (COVID-19) control measures that have been there from the start.

School closures were seen as a key way to prevent the spread of coronavirus disease 2019 (COVID-19), but were there other methods that would have been more effective and less harmful?

A report offers insight into how 7-valent and 13-valent pneumococcal vaccines could help prevent certain serotypes of otitis media.

A study examines whether a clinician can diagnose respiratory syncytial virus (RSV) from how a child's cough sounds.

A safe coronavirus 2019 disease (COVID-19) vaccine that can be administered to most of the pediatric population is a necessity for ending the pandemic, but trials for younger children have not occurred. The president of the American Academy of Pediatrics (AAP) wrote to key COVID-19 officials about the need to change this.

A case series offers insight on how to separate multisystem inflammatory syndrome in children (MIS-C) and severe acute coronavirus 2019 disease (COVID-19).

The US Food and Drug Administration (FDA) discussed its latest drug and testing efforts to respond to coronavirus 2019 disease.

With the authorization of 2 vaccines in late 2020 it seemed like a corner had been turned with the pandemic. A recent poll offers insight into how the public feels like the pandemic is going and when the disruptions caused by it might end.

As the 2020-2021 influenza season loomed, many in health care worried that the seasonal disease would add to the extraordinary burden of coronavirus disease 2019 and create a perfect storm. Have various prevention strategies helped prevent this potential issue?

A report offers much needed information on whether very young children are at greater risk of having a severe disease course of coronavirus 2019 (COVID-19).

Vaccine hesitancy is nothing new in pediatrics. However, the increased hesitancy for the COVID-19 vaccine could prove problematic.

The US Food and Drug Administration (FDA) issued an emergency use authorization (EUA) of monoclonal antibodies bamlanivimab and etesevimab to treat mild coronavirus disease 2019 (COVID-19) in both pediatric and adult patients.